2nd Victory for Xarelto Defendants
2nd Victory for Xarelto Defendants
Introduction
The jury for a second time, consecutively, ruled in favor of the defendants, J&J and Bayer, in the Xarelto Lawsuit trial. The defendant came in strong, stating that the death of the plaintiff was caused due to several other underlying conditions and not Xarelto. This verdict has further strengthened the manufacturer's count and would require a thorough preparation by the plaintiffs and their legal aid in the upcoming lawsuits. The next hearing is scheduled for this August, in Mississippi.
Comments
Latest News
Court Approves $700M Opioid Settlement for Acute Hospitals
Categories: Opioids
A federal court has approved a $700 million class-action settlement that will compensate over 1,000 acute care hospitals for costs related to the opioid crisis.
The settlement consolidates four separate agreements involving major drug…
Philips Settles CPAP Lawsuits Over Toxic Foam for $1.1B
Categories: Philips CPAP/BiPAP/ASV Sleep Apnea Machines
Philips has been embroiled in legal battles following the recall of millions of CPAP, BiPAP, and ventilator devices due to toxic foam degradation.
The breakdown of the foam in these machines may release harmful chemicals, raising serious…
Texas Trial to Decide J&J’s $10B Talcum Powder Settlement
Categories: Talcum
A high-stakes trial in Texas will determine whether Johnson & Johnson (J&J) can resolve tens of thousands of talcum powder cancer lawsuits through a…